Dr Reddy's Labs shares up 3% after Q2 results. What should investors do (...)
Dr. Reddy's Labs reported a 15% decline in Q2 net profit, despite a 17% rise in revenue driven by global generics. While analysts acknowledge the strong revenue momentum, opinions are divided on the stock's future prospects, with ratings ranging from 'Buy' to (...)
Site référencé: The Economic Times
The Economic Times
Rupee may hit record lows following US tariff shock
31/07/2025
Piramal Enterprises Q1 Results : Net profit surges 52% to Rs 276 crore on improved margins, lower credit costs
30/07/2025
NSE introduces 20% lower price cap for SME IPO pre-open session from August 4
30/07/2025
These 9 stocks show consistent growth in quarterly EPS
30/07/2025
